19.08.2015 Views

Occupational Exposure to Carbon Nanotubes and Nanofibers

Occupational Exposure to Carbon Nanotubes and Nanofibers

Occupational Exposure to Carbon Nanotubes and Nanofibers

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A.7.1 Particle CharacteristicsBoth types of CNF were vapor grown, but obtainedfrom different sources. In Murray et al. [2012], theCNF was supplied by Pyrograf Products, Inc. Thechemical composition was 98.6% wt. elemental carbon<strong>and</strong> 1.4% wt. iron. CNF structures were 80 <strong>to</strong>160 nm in diameter, <strong>and</strong> 5 <strong>to</strong> 30 µm in length. Thespecific surface area (SSA) measured by BET was 35-45 m 2 /g; the effective SSA was estimated as ~21 m 2 /g[Murray et al. 2012]. In DeLorme et al. [2012], theCNF was supplied by Showa Denko KK, Tokyo,Japan. The chemical composition was >99.5% carbon,0.03% oxygen <strong>and</strong> < 0.003% iron. CNF structureswere 40-350 nm (158 nm average) in diameter<strong>and</strong> 1-14 µm in length (5.8 µm average). The BETSSA was 13.8 m 2 /g [DeLorme et al. 2012].A.7.2 Experimental Design<strong>and</strong> AnimalsThe species <strong>and</strong> route of exposure also differed inthe two studies. In Murray et al. [2012], six femaleC57BL/6 mice (8-10 wk of age, 20.0 + 1.9 g bodyweight) were administered a single dose (120 µg) ofCNF by pharyngeal aspiration [Murray et al. 2012];mice were examined at 1, 7, <strong>and</strong> 28 days post-exposure.In DeLorme et al. [2012], female <strong>and</strong> maleCrl:CD Sprague Dawley rats (5 wk of age) were exposed<strong>to</strong> CNF by nose-only inhalation at exposureconcentrations of 0, 0.54, 2.5, or 25 mg/m 3 (6 hr/d,5 d/wk, 13 wk). The rats were examined 1-d afterthe end of the 13-wk exposure <strong>and</strong> 3 months postexposure.Body weights were reported as: 252 g +21.2 female; 520 g + 63.6 male (unexposed controls,1-d post-exposure); 329 g + 42.2 female; 684g + 45.8 male (unexposed controls, 3 mo. post-exposure)[DeLorme et al. 2012].A.7.3 Lung ResponsesIn mice, the lung responses <strong>to</strong> CNF included pulmonaryinflammation (polymorphonuclear lymphocytes,PMNs, measured in bronchioalveolarlavage fluid, BALF); PMN accumulation in CNFexposedmice was 150-fold vs. controls on day 1.NIOSH CIB 65 • <strong>Carbon</strong> <strong>Nanotubes</strong> <strong>and</strong> <strong>Nanofibers</strong>By day 28 post-exposure, PMNs in BALF of CNFexposedmice had decreased <strong>to</strong> 25-fold vs. controls.Additional lung effects included increased lungpermeability (elevated <strong>to</strong>tal protein in BALF), cy<strong>to</strong><strong>to</strong>xicity(elevated lactate dehydrogenase, LDH),which remained significantly elevated compared <strong>to</strong>controls at day 28 post-exposure. Oxidative damage(elevated 4-hydroxynonenol, 4-HNE, <strong>and</strong> oxidativelymodified proteins, i.e., protein carbonyls)was significantly elevated at days 1 <strong>and</strong> 7, but notat day 28. Collagen accumulation at day 28 postexposurewas 3-fold higher in CNF-exposed micevs. controls by biochemical measurements. Consistentwith the biochemical changes, morphometricmeasurement of Sirius red-positive type I <strong>and</strong> IIIcollagen in alveolar walls (septa) was significantlygreater than controls at day 28 post-exposure[Murray et al. 2012].In rats, the respira<strong>to</strong>ry effects observed in the De-Lorme et al. study [2012] were qualitatively similar<strong>to</strong> those found in the Murray et al study [2012]. Thewet lung weights were significantly elevated compared<strong>to</strong> controls in male rats at 25 mg/m 3 CNF <strong>and</strong>in female rats at 2.5 <strong>and</strong> 25 mg/m 3 CNF at 1-daypost-exposure; lung weights remained elevated ineach sex in the 25 mg/m 3 exposure group at 3 mo.post-exposure. His<strong>to</strong>pathologic changes at 1 daypost-exposure included inflammation in the terminalbronchiolar <strong>and</strong> alveolar duct region in the2.5 <strong>and</strong> 25 mg/m 3 exposure groups, <strong>and</strong> interstitialthickening with type II pneumocyte proliferationin the 25 mg/m 3 exposure group. Cell proliferationassays confirmed increased cell proliferation in thathighest dose group in the subpleural, parenchymal<strong>and</strong> terminal bronchiolar region; the subpleuralproliferation in this dose group did not resolve inthe females by the end of the 3 month recovery period.Cell proliferation appeared <strong>to</strong> resolve in malesafter a 3 month recovery period but numerically remainedhigher in the parenchyma <strong>and</strong> subpleuralregions. His<strong>to</strong>pathologic evidence of inflammation<strong>and</strong> the presence of fiber-laden macrophageswere reported <strong>to</strong> be reduced but still present in thehigh dose group after a 3 month recovery period.Inflammation within the alveolar space (as measuredby PMN levels in BALF) was statistically sig-139

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!